Verrica Pharmaceuticals
IPOVerrica Pharmaceuticals is headquartered in WEST CHESTER, United States and lists 11–50 employees.
- Headquarters
- WEST CHESTER, Pennsylvania
- Employees
- 11–50
- Business Model
- B2B
- Type
- Public
Indexed holds 1 investor for this company. The full record is or through the API.
About
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases that require medical intervention. Its lead product, YCANTH (cantharidin) topical solution 0.7%, became the first FDA-approved treatment for molluscum contagiosum in patients as young as two, a contagious viral skin infection affecting about six million people in the United States, primarily children. Verrica is commercializing YCANTH for molluscum, developing it for common warts, and advancing VP-315 for dermatologic oncology including basal cell and squamous cell carcinomas under a worldwide license with Lytix Biopharma.
Summary
Verrica Pharmaceuticals is a Biotech company based in WEST CHESTER, United States. It lists 11–50 employees. Investors include PBM Capital.
Exit History
Nov 2025
Sign up to see all 2 events
Funding, valuations, and company events, with amounts and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/verrica-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/verrica-pharmaceuticals" alt="Verrica Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>